Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03676725 · ClinicalTrials.gov registry record · Early Phase 1
Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD
A Early Phase 1 study, sponsored by PhenoSolve.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 90
- Enrollment target
NCT03676725 is a Early Phase 1 study that has completed, run by PhenoSolve. The registered enrollment target is 90 participants.
The verdict
NCT03676725, a Early Phase 1 study, has completed, sponsored by PhenoSolve.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
This work will assess the prevalence in the general population of the ineffectiveness of the anesthetic Lidocaine compared to males with ADHD and females with ADHD with or without PMS.
Interventions
- DRUG Lidocaine gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2019-08-14 |
| Est. Completion | 2020-03-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03676725
The ClinicalTrials.gov registry entry for NCT03676725 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PhenoSolve, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lidocaine gel is the first listed.
NCT03676725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03676725 about?
NCT03676725 is a clinical study titled "Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD". This work will assess the prevalence in the general population of the ineffectiveness of the anesthetic Lidocaine compared to males with ADHD and females with ADHD with or without PMS.
What is the current status of trial NCT03676725?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 90 participants. The study started on 2019-08-14. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT03676725?
The interventions under investigation include: Lidocaine gel (DRUG).
Who is sponsoring clinical trial NCT03676725?
This trial is sponsored by PhenoSolve, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.